Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $86.0000 (17.81%) ($70.5000 - $93.0000) on Tue. Mar. 17, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.67% (three month average) | RSI | 75 | Latest Price | $86.0000(17.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 4.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 13% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(7%) VT(7%) XLF(7%) EEM(6%) EWI(6%) | Factors Impacting CAPR price | CAPR will decline at least -4.335% in a week (0% probabilities). VIXM(-5%) TLT(-4%) GLD(-3%) SLV(-2%) SHY(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.335% (StdDev 8.67%) | Hourly BBV | 0 () | Intraday Trend | -1.7% | | | |
|
5 Day Moving Average | $75.98(13.19%) | 10 Day Moving Average | $74.33(15.7%) | 20 Day Moving Average | $67.38(27.63%) | To recent high | 0% | To recent low | 152.9% | Market Cap | $1.694b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |